Advertisement

Topics

Discovery Institute Company Profile

16:08 EST 20th November 2017 | BioPortfolio


News Articles [863 Associated News Articles listed on BioPortfolio]

A new approach to cancer drug discovery

(Scripps Research Institute) Scientists at The Scripps Research Institute (TSRI) have developed and demonstrated a promising new strategy for the discovery of novel anti-cancer therapies.

Where do heart cells come from?

(Sanford-Burnham Prebys Medical Discovery Institute) Researchers from Sanford Burnham Prebys Medical Discovery Institute, the Cardiovascular Institute at Stanford University and other institutions wer...

Feinstein Institute discovery challenges belief about brain's cellular makeup

(Northwell Health) A discovery made by Junhwan Kim, PhD, assistant professor at The Feinstein Institute for Medical Research, is challenging science's longstanding beliefs regarding the cellular makeu...

New clues to treat Alagille Syndrome from zebrafish

(Sanford-Burnham Prebys Medical Discovery Institute) A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies potential new therapeutic avenues for patient...

The Francis Crick Institute: Discovery without boundaries

Dr David Roblin (keynote speaker at the 2016 On Helix conference and Chief Operating Officer and Director of Scientific Translation at The Francis Crick Institute) discusses the soon-to-be opened Fran...

ChemDiv discovery platform tapped to advance R&D pipeline into preclinical studies

The Tri-Institutional Therapeutics Discovery Institute, Inc. will use ChemDiv's proprietary discovery chemistry platform to advance its research and development (R&D) pipeline.

Discovery Zone

Last spring, veteran pharmaceutical executive and entrepreneur Dr. William Polvino was tapped as CEO of Bridge Medicines, a company established in October 2016 to further the development of drugs nurt...

Discovering potential therapeutic protein inhibitors for Chagas disease

(Tokyo Institute of Technology) Scientists at Tokyo Institute of Technology (Tokyo Tech), Nagasaki University have identified four potential protein inhibitors and unlocked drug discovery strategies f...

Drugs and Medications [31 Associated Drugs and Medications listed on BioPortfolio]

Caraderma [A Refreshing Discovery, Inc.]

CaraDerma acne treatment

Eczenil [Healingsmith Institute Inc.]

Psoracare [Healingsmith Institute Inc.]

Elliotts b [QOL Medical LLC]

ELLIOTTS B SOLUTION (buffered intrathecal electrolyte/dextrose injection) Rx Only

Clinpro 5000 [3M ESPE Dental Products]

These highlights do not include all the information needed to use 3M™ ESPE™ Clinpro 5000 Anti-Cavity Toothpaste safely and effectively. See full prescribing information for Clinpro 5000 Anti-Cavit...

PubMed Articles [960 Associated PubMed Articles listed on BioPortfolio]

The Tanenbaum Open Science Institute: Leading a Paradigm Shift at the Montreal Neurological Institute.

The Montreal Neurological Institute is adopting an Open Science Policy that will be enacted by the Tanenbaum Open Science Institute. The aim is to accelerate the generation of knowledge and novel effe...

The Future of Radiobiology.

Innovation and progress in radiation oncology depend on discovery and insights realized through research in radiation biology. Radiobiology research has led to fundamental scientific insights, from th...

Protac-induced Protein Degradation in Drug Discovery: Breaking the Rules - or Just Making New Ones?

Targeted protein degradation, using bifunctional small molecules (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer the...

The Utility of Target-Based Discovery.

18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT.

To evaluate if the new Discovery Molecular Insights (DMI) PET/CT scanner provides equivalent results compared to the standard of care PET/CT scanners (GE Discovery 600 or GE Discovery 690) used in our...

Clinical Trials [654 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Postmenopausal Estrogen/Progestin Interventions (PEPI)

To assess the effects of various postmenopausal estrogen replacement therapies on selected cardiovascular risk factors, including high density lipoprotein cholesterol, systolic blood press...

Companies [2215 Associated Companies listed on BioPortfolio]

Institute for Diabetes Discovery

The Institute for Diabetes Discovery, LLC, (IDD) is the largest privately-held biopharmaceutical company in the United States dedicated to the research and discovery of novel drugs and therapeutics fo...

Medco Research Institute

Medco Research Institute(TM) is an evidence-based research organization focused solely on novel research, analytics and new discoveries that close the gap between scientific discovery and medical prac...

The Richard B. and Lynne V. Cheney Cardiovascular Institute

The Richard B. and Lynne V. Cheney Cardiovascular Institute at The George Washington University was established in 2006. The Institute's mission is to promote clinical research, education, patient ca...

Robarts Research Institute

Opened in 1986, Robarts Research Institute is a non-profit medical research facility in London, Ontario, with more than 600 people working to investigate some of the most debilitating diseases of our ...

BioAnalyte Inc.

BioAnalyte Inc. is your biomarker discovery partner. We illuminate the path between data and discovery by connecting analytical instrumentation users to the answers that they seek. Our depth of knowle...

More Information about "Discovery Institute" on BioPortfolio

We have published hundreds of Discovery Institute news stories on BioPortfolio along with dozens of Discovery Institute Clinical Trials and PubMed Articles about Discovery Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Discovery Institute Companies in our database. You can also find out about relevant Discovery Institute Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record